作者: Philip J. Disaia
关键词:
摘要: Background. It has been common practice to prohibit hormone-replacement therapy (HRT) in patients with breast cancer. A reappraisal of this is necessary because hundreds reports have established the benefits HRT coronary artery disease, osteoporosis, serum lipid profile, and quality life. Methods. An argument presented support safety use such absence a prospective randomized study addressing these issues. This relies primarily on historical data. Results. There no direct evidence that adversely affects who previously afflicted cancer